Vetr Crowd Doesn't Like Outlook For Clovis Oncology
November 23, 2016 at 15:44 PM EST
On Wednesday, the Vetr crowd downgraded their rating for Clovis Oncology Inc (NASDAQ: CLVS) from 3 stars (Hold) to 2.5 stars (Sell). ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.